Unibest

Pharmaceutical intermediates

Avatrombopag Maleate Intermediates

4 pharmaceutical intermediates for Avatrombopag Maleate. Indication: Idiopathic Thrombocytopenic Purpura (ITP); Thrombocytopenia.

Submit a ProjectAll intermediates

About Avatrombopag Maleate

Originator
Astellas Pharma Inc.
Indication
Idiopathic Thrombocytopenic Purpura (ITP); Thrombocytopenia
Approved Date
05/21/2018
DS/DP
07/28/2027

Available intermediates

4 intermediates currently listed for Avatrombopag Maleate. Request specifications, documentation or a quotation for any item below.

Avatrombopag Maleate intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
4-(4-chloro-2-thienyl)-2-ThiazolaMine570407-10-2//
4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine570407-42-0//
1-Cyclohexylpiperazine17766-28-8//
5,6-Dichloronicotinic acid41667-95-2//

Other programs under A

AbemaciclibAbrocitinibAcalabrutinibAdagrasibAfatinibAfoxolanerAlectinib HydrochlorideAlfacalcidol

Building toward Avatrombopag Maleate?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

Submit a Project Talk to the team

How can we help you?

Receive insights into the latest events and regulatory updates

Sent directly to your email

Get industry insights and Unibest news here

Contact Us →